======= USP47 =======
== Gene Information ==
* **Official Symbol**: USP47
* **Official Name**: ubiquitin specific peptidase 47
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55031|55031]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96K76|Q96K76]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=USP47&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20USP47|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614460|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Ubiquitin-specific protease that specifically deubiquitinates monoubiquitinated DNA polymerase beta (POLB), stabilizing POLB thereby playing a role in base-excision repair (BER). Acts as a regulator of cell growth and genome integrity. May also indirectly regulate CDC25A expression at a transcriptional level. {ECO:0000269|PubMed:19966869, ECO:0000269|PubMed:21362556}.
|UCH|
|WD40-repeat domain binding|
|ubiquitinyl hydrolase activity|
|monoubiquitinated protein deubiquitination|
|negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage|
|base-excision repair|
|regulation of intrinsic apoptotic signaling pathway in response to DNA damage|
|thiol-dependent ubiquitinyl hydrolase activity|
|SCF ubiquitin ligase complex|
|negative regulation of response to DNA damage stimulus|
|negative regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|cellular response to UV|
|negative regulation of G2/M transition of mitotic cell cycle|
|negative regulation of cysteine-type endopeptidase activity|
|cysteine-type endopeptidase activity|
|negative regulation of intrinsic apoptotic signaling pathway|
|negative regulation of cell cycle G2/M phase transition|
|thiol-dependent ubiquitin-specific protease activity|
|cellular response to light stimulus|
|response to UV|
|positive regulation of canonical Wnt signaling pathway|
|regulation of intrinsic apoptotic signaling pathway|
|positive regulation of cell growth|
|cellular response to radiation|
|positive regulation of Wnt signaling pathway|
|regulation of G2/M transition of mitotic cell cycle|
|regulation of cell cycle G2/M phase transition|
|negative regulation of mitotic cell cycle phase transition|
|regulation of cysteine-type endopeptidase activity involved in apoptotic process|
|regulation of response to DNA damage stimulus|
|negative regulation of apoptotic signaling pathway|
|negative regulation of cell cycle phase transition|
|regulation of cysteine-type endopeptidase activity|
|negative regulation of endopeptidase activity|
|negative regulation of peptidase activity|
|positive regulation of growth|
|regulation of canonical Wnt signaling pathway|
|protein deubiquitination|
|regulation of protein stability|
|protein modification by small protein removal|
|negative regulation of mitotic cell cycle|
|response to light stimulus|
|cellular response to environmental stimulus|
|cellular response to abiotic stimulus|
|negative regulation of cell cycle process|
|negative regulation of proteolysis|
|regulation of Wnt signaling pathway|
|regulation of apoptotic signaling pathway|
|regulation of mitotic cell cycle phase transition|
|regulation of endopeptidase activity|
|regulation of cell growth|
|response to radiation|
|regulation of peptidase activity|
|regulation of cell cycle phase transition|
|negative regulation of hydrolase activity|
|negative regulation of intracellular signal transduction|
|DNA repair|
|ubiquitin-dependent protein catabolic process|
|modification-dependent protein catabolic process|
|modification-dependent macromolecule catabolic process|
|negative regulation of cell cycle|
|proteolysis involved in cellular protein catabolic process|
|cellular protein catabolic process|
|regulation of mitotic cell cycle|
|regulation of growth|
|protein catabolic process|
|regulation of proteolysis|
|regulation of cellular response to stress|
|DNA metabolic process|
|regulation of cell cycle process|
|cellular response to DNA damage stimulus|
|negative regulation of catalytic activity|
|negative regulation of apoptotic process|
|negative regulation of programmed cell death|
|cellular macromolecule catabolic process|
|protein modification by small protein conjugation or removal|
|negative regulation of cell death|
|response to drug|
|negative regulation of cellular protein metabolic process|
|macromolecule catabolic process|
|organonitrogen compound catabolic process|
|negative regulation of protein metabolic process|
|negative regulation of molecular function|
|response to abiotic stimulus|
|regulation of cell cycle|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of signal transduction|
|proteolysis|
|regulation of hydrolase activity|
|negative regulation of RNA metabolic process|
|negative regulation of cell communication|
|negative regulation of signaling|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|regulation of response to stress|
|negative regulation of cellular biosynthetic process|
|regulation of apoptotic process|
|negative regulation of biosynthetic process|
|regulation of programmed cell death|
|negative regulation of response to stimulus|
|positive regulation of signal transduction|
|regulation of cell death|
|cellular response to stress|
|negative regulation of gene expression|
|organic substance catabolic process|
|cellular catabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.72|
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|1.98|
^Gene^Correlation^
|[[:human genes:g:golga6l1|GOLGA6L1]]|0.433|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8143
* **Expression level (log2 read counts)**: 6.76
{{:chemogenomics:nalm6 dist.png?nolink |}}